XML 37 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Initial Public Offering
Convertible Preferred Stock
Convertible Preferred Stock
Initial Public Offering
Voting Common Stock
Non-voting Common Stock
Common Stock
Voting Common Stock
Common Stock
Voting Common Stock
Initial Public Offering
Common Stock
Non-voting Common Stock
Common Stock
Non-voting Common Stock
Initial Public Offering
Additional Paid-In Capital
Additional Paid-In Capital
Initial Public Offering
Accumulated Deficit
Balances at Dec. 31, 2020 $ (42,462)           $ 1       $ 1,070   $ (43,533)
Balances, shares at Dec. 31, 2020     7,063,104                    
Balances at Dec. 31, 2020     $ 59,681                    
Balances, shares at Dec. 31, 2020             1,135,858            
Issuance of Series C convertible preferred stock (net of issuance costs of $270 thousand)     $ 99,730                    
Issuance of Series C convertible preferred stock (net of issuance costs of $270 thousand), shares     8,553,168                    
Issuance of common stock, net of issuance costs 89,646           $ 1       89,645    
Issuance of common stock, net of issuance costs, shares             6,666,667            
Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering       $ 159,411                  
Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering, shares       15,616,272                  
Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering   $ 159,412               $ 1   $ 159,411  
Conversion of convertible preferred stock to common stock and non-voting common stock upon closing of initial public offering, shares               10,473,138   5,143,134      
Exercise of stock options 291                   291    
Exercise of stock options, shares             167,390            
Vesting of restricted common stock, shares             321,410            
Stock-based compensation expense 2,516                   2,516    
Net loss (48,625)                       (48,625)
Balances at Dec. 31, 2021 160,778           $ 2   $ 1   252,933   (92,158)
Balances, shares at Dec. 31, 2021         18,764,463 5,143,134 18,764,463   5,143,134        
Issuance of common stock, net of issuance costs 193                   193    
Issuance of common stock, net of issuance costs, shares             146,380            
Exercise of stock options 133                   133    
Exercise of stock options, shares             55,107            
Vesting of restricted common stock, shares             116,870            
Stock-based compensation expense 4,551                   4,551    
Net loss (66,221)                       (66,221)
Balances at Dec. 31, 2022 $ 99,434           $ 2   $ 1   $ 257,810   $ (158,379)
Balances, shares at Dec. 31, 2022         19,082,820 5,143,134 19,082,820   5,143,134